Re-Q Pro-Longevity Serum + Intense Pulsed Light for Photoaging

AP
Overseen ByAndrea Pacheco
Age: 18+
Sex: Female
Trial Phase: Phase 2 & 3
Sponsor: Goldman, Butterwick, Fitzpatrick and Groff
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The primary objective is to compare Re-Q Pro-Longevity serum versus vehicle serum combined with Intense Pulsed Laser for the treatment of moderate to severe photodamage and crepiness on the dorsal forearms.

Are You a Good Fit for This Trial?

This trial is for people with moderate to severe sun damage and crepey skin on their forearms. Participants should be adults who can safely receive light-based treatments and topical serums.

Inclusion Criteria

Willing to maintain the study skincare regimen and refrain from introducing new topical or procedural treatments to the forearms during the study period
Negative urine pregnancy test at all visits for participants of childbearing potential
Willing and able to comply with all study requirements including scheduled visits, treatment protocol, and follow-up assessments
See 6 more

Exclusion Criteria

Active smoking or use of nicotine-containing products within 6 months prior to enrollment
Participation in any other interventional clinical study within 30 days prior to enrollment or during this study
Suntan or use of sunless tanner/spray-tan in the treatment areas within 4 weeks prior to study treatment
See 11 more

What Are the Treatments Tested in This Trial?

Interventions

  • Intense Pulsed Light Therapy
  • Re-Q Pro-Longevity Serum
  • Vehicle Serum

Trial Overview

The study compares two treatments on each participant: one forearm gets Re-Q Pro-Longevity serum plus Intense Pulsed Light (IPL) therapy, while the other gets a placebo serum plus IPL. The goal is to see which combination works better for improving sun-damaged, crepey skin.

How Is the Trial Designed?

2

Treatment groups

Active Control

Placebo Group

Group I: Group A Right Arm Treated with Active Re-Q Pro-Longevity Serum and Intense Pulsed Light TherapyActive Control1 Intervention
Group II: Group B Left Arm Treated with Vehicle serum and Intense Pulsed Light TherapyPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Goldman, Butterwick, Fitzpatrick and Groff

Lead Sponsor

Trials
32
Recruited
660+

Rapalogix

Collaborator